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Summary and Implications 
 Bovine mammary epithelial cells that were treated with 
bacterial lipopolysaccharide and 1,25-dihydroxyvitamin D3 
showed an increase in the expression of the genes for 
inducible nitric oxide synthase (iNOS) and S100 calcium 
binding protein A12 (S100 A12).  iNOS and S100 A12 are 
part of the innate immune response and expressed in the 
mammary gland during mastitis. Production of 1,25-
dihydroxyvitamin D3 in the mammary gland during mastitis, 
then, may be an important component of the innate immune 
response. 
 
Introduction 
 The active form of vitamin D3 is 1,25-dihydroxyvitamin 
D3 (1,25(OH)2D3). 1,25(OH)2D3 binds and activates the 
vitamin D receptor (VDR), a nuclear hormone receptor that 
regulates the expression of genes that contain a vitamin D 
response element in their promoter.  1,25(OH)2D3 is 
produced from 25-hydroxyvitamin D3 (25(OH)D3), the 
predominant circulating form of vitamin D3, by the enzyme 
1 -hydroxylase (1 -OHase).  We have recently shown that 
bovine monocytes express 1 -OHase in response to toll-like 
receptor (TLR) recognition of bacteria.  Production of 
1,25(OH)2D3 by 1 -OHase in activated bovine monocytes 
increased production of nitric oxide and expression of the 
chemokine RANTES in monocytes.  We also have observed 
that 1 -OHase is expressed in inflamed mammary tissue 
during mastitis.  Mammary epithelial cells are involved in 
protecting the mammary gland from bacterial infection and 
production of 1,25(OH)2D3 by 1 -OHase in the mammary 
gland may affect their innate immune function. The 
objective of this experiment was to determine the effects of 
1,25(OH)2D3 and lipopolysaccharide (LPS) on iNOS, 
RANTES, and S100 calcium binding protein A12 (S100 
A12) gene expression in bovine mammary epithelial cells 
(MEC).  
 
Materials and Methods 
 MEC were derived from mammary tissue biopsies of 
three Holstein cows in mid-lactation.  The cells were 
cultured in RPMI 1640 plus 10% fetal bovine serum and 
mammary epithelial growth supplement (Invitrogen).  Prior 
to treatment, MEC were transferred to 96-well tissue culture 
treated plates and cultured until they were confluent.  MEC 
were treated with 0 or 1 g/mL LPS along with 0, 0.1, 1 or 
10 nM 1,25(OH)2D3 for 16 hours. After treatment, total 
RNA was isolated from MEC and reverse transcribed to 
cDNA.  Quantitative real-time PCR using the 2
- Ct
 method 
was used to measure relative abundance of 24-hydroxylase 
(24-OHase), iNOS, RANTES and S100 A12.  Ribosomal 
protein S9 (RPS9) was used as the reference gene. 
 
Results and Discussion 
 Treatment of MEC with 1,25(OH)2D3 caused an 
increase in 24-OHase gene expression in a dose dependent 
manner in both the presence and absence of LPS (Figure 
1A).  The 24-OHase enzyme adds a hydroxyl group to the 
24 position of vitamin D metabolites, which inactivates 
1,25(OH)2D3.  In bovine monocytes, induction of 24-OHase 
expression by 1,25(OH)2D3 was repressed by LPS 
treatment, so regulation of 24-OHase expression differs 
between monocytes and MEC. 
 In MEC treated with LPS, both iNOS and S100 A12 
gene expression increased with 1,25(OH)2D3 dose (Figure 
1B and C).  Increased expression of iNOS resulted in 
increased nitric oxide production by MEC (not shown).  
Nitric oxide may increase antimicrobial activity and blood 
flow in the mammary gland during mastitis, but it also may 
lead to MEC apoptosis.  The function of S100 A12 is not 
completely understood, but it has been shown to have 
chemotactic and antimicrobial properties. 
 RANTES expression in MEC did not increase with 
1,25(OH)2D3 treatment (Figure 1D).  Treatment with LPS, 
however, caused an increase in MEC RANTES expression.  
In contrast, RANTES expression was up-regulated by 
1,25(OH)2D3 treatment in LPS-stimulated bovine 
monocytes, but was not affected by LPS treatment alone. 
 In conclusion, 1,25(OH)2D3 acts in bovine MEC to 
enhance expression of iNOS and S100 A12 that is induced 
by TLR recognition of LPS.  Therefore, production of 
1,25(OH)2D3 by 1 -OHase in the mammary gland during 
mastitis may affect the host defense capabilities of MEC.  
Production of 1,25(OH)2D3 by 1 -OHase is dependent on 
availability of 25(OH)D3. The circulating concentration of 
25(OH)D3 is dependent on acquisition of vitamin D3 in the 
diet or in skin exposed to sunlight.  So, dietary intake of 
vitamin D3 and exposure to sun may affect incidence and 
severity of mastitis in cattle.   
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Figure 1.  Mammary epithelial cell cultures were treated with 0 or 1 g/mL LPS and 0 to 10 nM 1,25-dihydroxyvitamin D3 
for 16 hours.  The amount of 24-hydroxylase (24-OHase; A), inducible nitric oxide synthase (iNOS; B), S100 calcium 
binding protein A12 (S100 A12; C), and RANTES (D) mRNA in MEC was measured by quantitative PCR.  The expression 
of each gene was normalized to ribosomal protein S9 expression.  The fold increase is relative to the control treatment.  
Results are the average of three separate experiments done in duplicate. Cells were from different cows for each experiment.  
Error bars represent standard error.  Means with different letters are different (P < 0.05). 
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